CR20220112A - Composiciones que comprenden tigolaner para el control de parásitos - Google Patents

Composiciones que comprenden tigolaner para el control de parásitos

Info

Publication number
CR20220112A
CR20220112A CR20220112A CR20220112A CR20220112A CR 20220112 A CR20220112 A CR 20220112A CR 20220112 A CR20220112 A CR 20220112A CR 20220112 A CR20220112 A CR 20220112A CR 20220112 A CR20220112 A CR 20220112A
Authority
CR
Costa Rica
Prior art keywords
tigolaner
compositions
controlling parasites
parasites
controlling
Prior art date
Application number
CR20220112A
Other languages
English (en)
Inventor
Gabriele Petry
David Siegel
Iris Heep
Elisabeth Feldhues
Venkata-Rangarao Kanikanti
Original Assignee
Vetoquinol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol Sa filed Critical Vetoquinol Sa
Publication of CR20220112A publication Critical patent/CR20220112A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

La presente invención se refiere a una composición que comprende tigolaner y, opcionalmente, agentes endoparasiticidas, un método para su fabricación y su uso como un medicamento para el control de parásitos.
CR20220112A 2019-08-14 2020-08-12 Composiciones que comprenden tigolaner para el control de parásitos CR20220112A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19191727 2019-08-14
PCT/EP2020/072640 WO2021028479A1 (en) 2019-08-14 2020-08-12 Compositions comprising tigolaner for controlling parasites

Publications (1)

Publication Number Publication Date
CR20220112A true CR20220112A (es) 2022-06-21

Family

ID=67658818

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20220112A CR20220112A (es) 2019-08-14 2020-08-12 Composiciones que comprenden tigolaner para el control de parásitos

Country Status (17)

Country Link
US (1) US20220331314A1 (es)
EP (1) EP4013388A1 (es)
JP (1) JP2022544537A (es)
KR (1) KR20220054319A (es)
CN (1) CN114698369A (es)
AU (1) AU2020328863A1 (es)
BR (1) BR112022002623A2 (es)
CA (1) CA3147171A1 (es)
CO (1) CO2022002898A2 (es)
CR (1) CR20220112A (es)
EC (1) ECSP22012650A (es)
IL (1) IL290597A (es)
MX (1) MX2022001764A (es)
TW (1) TW202122079A (es)
UY (1) UY38841A (es)
WO (1) WO2021028479A1 (es)
ZA (1) ZA202202672B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20231205A1 (es) 2020-05-29 2023-08-17 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos como anthelminticos
WO2022268813A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105064A1 (en) * 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105065A1 (en) * 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE211466T1 (de) 1992-03-17 2002-01-15 Fujisawa Pharmaceutical Co Depsipeptide, herstellung und anwendung
DE4400464A1 (de) 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE102004020721A1 (de) 2004-04-28 2005-11-24 Bayer Healthcare Ag Dermal applizierbare flüssige Formulierungen zur Bekämpfung von parasitierenden Insekten an Tieren
DE102005011779A1 (de) 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102006061538A1 (de) 2006-12-27 2008-07-03 Bayer Healthcare Ag Kombinationsprodukt zur Bekämpfung von Parasiten an Tieren
WO2014012975A1 (en) 2012-07-19 2014-01-23 Bayer Cropscience Ag Process for the preparation of 5-fluoro-1h-pyrazoles
KR102191469B1 (ko) 2013-02-06 2020-12-16 바이엘 애니멀 헬스 게엠베하 해충 방제제로서의 할로겐-치환된 피라졸 유도체
CN105934429B (zh) 2013-11-27 2022-03-04 拜耳动物保健有限责任公司 制备5-氟-1h-吡唑的方法
WO2015078847A1 (en) 2013-11-27 2015-06-04 Bayer Cropscience Ag Process for the preparation of 5-fluoro-1h-pyrazoles
WO2015150302A1 (en) 2014-04-01 2015-10-08 Bayer Cropscience Ag Process for the preparation of n-[3-(benzylcarbamoyl)phenyl]-1 h-pyrazole-5-carboxamides
TWI694066B (zh) 2014-05-27 2020-05-21 德商拜耳動物保健有限公司 始於六氟丙烯之製備5-氟-1h-吡唑的方法
MX369501B (es) 2014-08-19 2019-11-11 Bayer Animal Health Gmbh Proceso para la preparación de 5-fluoro-1h-pirazoles partiendo de hexafluoropropeno.
WO2016177619A1 (en) 2015-05-05 2016-11-10 Syngenta Participations Ag Method of control of stinkbugs
AR104691A1 (es) * 2016-05-18 2017-08-09 Labyes De Uruguay S A Composición veterinaria de imidacloprid, moxidectina y praziquantel de administración tópica cutánea (spot on) para tratamiento y prevención de las ecto y endoparasitosis que afectan a los perros
US11344532B2 (en) * 2017-09-06 2022-05-31 Bayer Animal Health Gmbh Topically administrable formulation for the control and prevention of animal parasites
JP2019094270A (ja) * 2017-11-17 2019-06-20 日産化学株式会社 有害生物防除用組成物及び有害生物の防除方法

Also Published As

Publication number Publication date
CN114698369A (zh) 2022-07-01
AU2020328863A1 (en) 2022-04-07
US20220331314A1 (en) 2022-10-20
ZA202202672B (en) 2023-05-31
WO2021028479A1 (en) 2021-02-18
IL290597A (en) 2022-04-01
MX2022001764A (es) 2022-08-04
ECSP22012650A (es) 2022-03-31
KR20220054319A (ko) 2022-05-02
CO2022002898A2 (es) 2022-04-19
TW202122079A (zh) 2021-06-16
UY38841A (es) 2021-02-26
EP4013388A1 (en) 2022-06-22
CA3147171A1 (en) 2021-02-18
BR112022002623A2 (pt) 2022-05-03
JP2022544537A (ja) 2022-10-19

Similar Documents

Publication Publication Date Title
MX2022001764A (es) Composiciones que comprenden tigolaner para el control de parasitos.
LT3577110T (lt) 8-oksetan-3-il-3,8-diazabiciklo[3.2.1]oktan-3-ilo pakeistieji junginiai, kaip živ inhibitoriai
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
AU2015279424A8 (en) Difluoromethyl-nicotinic-indanyl carboxamides
MX2019011496A (es) Composiciones de niraparib.
PH12019502851A1 (en) New azaquinoline derivatives
MX2017011711A (es) Mejora en o con relacion a compuestos organicos.
MX2022010755A (es) Inhibidores de quinasa y usos de los mismos.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MY177933A (en) Herbicidal composition comprising quizalofop-p
WO2018127612A3 (en) Compositions comprising lespedeza plant extract
IL284800A (en) Methods, uses and compositions
EP3760195A4 (en) COMPOSITION WITH 2,3-BUTANEDIOL AS THE ACTIVE SUBSTANCE
MX2017007955A (es) Formas solidas que comprenden (1e, 4e)-2-amino-n,n-dipropil-8-(4-( pirrolidina-1-carbonil)fenil)-3h-benzo[b]azepina-4-carboxamida, composiciones de las mismas y usos de las mismas.
MY152388A (en) Composition and method for controlling plant diseases
GB201915828D0 (en) Compounds, compositions and therapeutic uses thereof
MX2016013439A (es) Formas solidas de un compuesto farmaceuticamente activo.
MX2020003598A (es) Composicion de material de revestimiento a base de yeso para moldeo y metodo de fabricacion de composicion de material de revestimiento a base de yeso para moldeo.
EP3610869A4 (en) COMPOSITION CONTAINING SARPOGRELATE AS AN ACTIVE INGREDIENT, FOR THE PREVENTION OR TREATMENT OF NEUROSENSORY HEARING LOSS
MX2022007663A (es) Tieniloxazolonas y analogos.
CR20220292A (es) Tiofenocarboxamidas sustituidas y sus derivados
EP4052761A4 (en) PERFUME COMPOSITION
EP3998327A4 (en) PERFUME COMPOSITION
MX2019000977A (es) Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación.
MX2018008730A (es) Metodos y composiciones para el control de las hormigas cultivadoras de hongos.